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Abstract There have long been suggestions that
aging is tightly linked to the complex dynamics of the
physiological systems that maintain homeostasis, and
in particular to dysregulation of regulatory networks
of molecules. This review synthesizes recent work that
is starting to provide evidence for the importance of
such complex systems dynamics in aging. There is
now clear evidence that physiological dysregulation—
the gradual breakdown in the capacity of complex
regulatory networks to maintain homeostasis—is an
emergent property of these regulatory networks, and
that it plays an important role in aging. It can be
measured simply using small numbers of biomarkers.
Additionally, there are indications of the importance
during aging of emergent physiological processes,
functional processes that cannot be easily understood
through clear metabolic pathways, but can nonetheless
be precisely quantified and studied. The overall role of
such complex systems dynamics in aging remains an
important open question, and to understand it future
studies will need to distinguish and integrate related
aspects of aging research, including multi-factorial
theories of aging, systems biology, bioinformatics,
network approaches, robustness, and loss of
complexity.
Keywords Systems biology  Aging  Statistical
distance  Physiological dysregulation  Principal
components analysis  Emergent property
Introduction
Twenty-five years ago, Medvedev (1990) outlined
more than 300 mechanistic theories of aging. The
question then, and the question now, was what to make
of this diversity of theories. Is one theory right to the
exclusion of all others? Do many mechanisms operate
simultaneously? Are some mechanisms downstream
and others upstream, such that we might identify one or
a few key upstream mechanisms? Do the mechanisms
interact with each othThe Author(s)er, and if so, how?
To some extent, we have answers to some of these
questions. For example, very few researchers would
now contend that there is a single aging mechanism,
though some still argue principally for one central
mechanism (Barja 2014). There is both theoretical and
empirical evidence for interactions among mechan-
isms (Kowald and Kirkwood 1996; Ludlow et al.
2014). However, we are still far from a general
consensus on a big-picture theory for how mechanisms
interact to cause aging (Kirkwood 2011).
One integrative theory proposes a breakdown in
interactions within the complex regulatory networks
that maintain homeostasis (Ferrucci 2005; Fried et al.
2005). This idea has been around in various forms for a
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long time, and has many names: homeostenosis
(Taffett 2003), allostatic load (Karlamangla et al.
2002; McEwen 1998), and physiological dysregula-
tion (Seplaki et al. 2005). Loss of complexity during
aging is a related idea that has also been developed in
detail (Lipsitz 2004; Lipsitz and Goldberger 1992;
Manor and Lipsitz 2013). These ideas are attractive,
and have garnered a fair amount of support, par-
ticularly among clinical aging researchers, though
they are less familiar to some researchers focused on
the molecular mechanisms of aging. However, the
challenge has been to accumulate evidence for the
importance of such complex systems dynamics in
aging. Precisely because the systems are complex,
they can be hard to measure. For example, measure-
ment of allostatic load has been questioned as circular
(Singer et al. 2004).
Over the last several years, my lab has been
working to find ways to test for the presence and
importance of complex systems dynamics in aging.
We have been doing so at the organism level, and
using a particular model of physiological organization.
Our approach to complex systems dynamics is
described in substantial detail below; briefly, I define
complex systems dynamics as changes in the state of
complex regulatory networks of molecules that
(a) arise due to the structure of regulatory relationships
within the network, such as through feedback loops,
that (b) cannot be easily understood via simple maps of
network structure (i.e., that represent emergent prop-
erties of the system), and that (c) may be sensitive to
the precise structure of the network and to perturba-
tions in it. Complex systems dynamics might be
implicated in aging via a breakdown in the regulatory
dynamics (‘‘dysregulation’’), through intricate feed-
back effects among aging mechanisms, or perhaps
through other mechanisms, as I will show.
The objective of this article is to summarize our
recent findings in an integrative way, and to relate
them to the broader literature on complex systems and
aging. I thus start with an overview of different ways
that complexity has been discussed in the context of
aging biology. I continue with a summary of our
model of physiological organization, including the
evidence we have generated for two particular types
of complex systems dynamics: emergent physio-
logical processes (EPPs) and physiological dysregula-
tion. Lastly, I integrate our findings into the larger
literature and summarize outstanding questions.
Approaches to complexity in aging
West and Bergman (2009) proposed an expanded role
for systems biology and complexity in aging, but there
are many directions this could take, and a lack of clear
terminology sometimes leads to confusion. It is
important to distinguish complex system dynamics
(our approach, detailed in the next section), multi-
factorial theories of aging (Kirkwood 2005), systems
biology and bioinformatics of aging more generally
(de Magalha˜es and Toussaint 2004; Kirkwood 2011;
Soltow et al. 2010), system-level robustness in aging
(Kriete 2013), and loss of complexity in aging (Lipsitz
2004; Lipsitz and Goldberger 1992). Each of these
research directions provides a critical piece of the
puzzle on complexity in aging, and long-term it will be
important to integrate them, and perhaps others.
Multi-factorial theories of aging posit simply that
aging has many causes (Weinert and Timiras 2003);
most aging researchers today would subscribe to this
idea at some level. Aging could be multi-factorial but
not involve complex system dynamics. For example,
there could be a number of different mechanisms that
cause damage accumulation, each proceeding largely
independently. Even if there are a few specific
feedback effects among the mechanisms (e.g. Kowald
and Kirkwood 1996), it is not a foregone conclusion
that there would be complex system dynamics. The
disposable soma theory and related mechanistic
theories based on the accumulation of damage, wear
and tear, etc. are multi-factorial but do not necessarily
imply complex system dynamics (Kirkwood 2005). In
fact, the evolutionary mechanisms referred to in the
disposable soma theory imply that complex systems
dynamics are not central to aging: if they were, aging
would likely evolve based on regulatory constraints in
complex networks, rather than based on a large
number of small trade-offs of things like energy
allocation (Cohen Accepted). The distinction between
multi-factorial theories and complex systems theories
may thus also be important for inferring how aging
evolved (see also Kriete 2013; Wensink et al. 2014).
While aging might be multi-factorial but without
complex systems dynamics, the reverse is unlikely to
be true. Complex systems explanations imply inter-
actions among sub-networks, and it is nearly certain
that this would involve complex feedback loops where
problems in one system cause problems in another,
etc. (Fried et al. 2009; Govindaraju et al. 2014).
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Multiple systems would thus be implicated in aging,
and dysregulatory processes could be started or
accelerated from many parts of the network. Further-
more, even if complex system dynamics are important
in aging, they are unlikely to be the sole factor. For
example, a trade-off between risk of cancer and
regenerative capacity appears to be involved in aging
(Park et al. 2004). This is likely largely independent of
complex systems dynamics.
The complex systems dynamics approach I take fits
solidly within a larger systems biology perspective as
outlined by Kitano (2002), in which four key features are
studied: structure, dynamics, control, and design. I would
add function as a fifth feature: what does the system
achieve for the organism? In this view, an integrated
approach to these features is necessary, though it will not
always be possible to conduct research that covers all
features. For example, our approach integrates dynamics
and function through an understanding of design prin-
ciples, but there is little emphasis on control or structure.
In contrast, Kirkwood (2011) puts an emphasis on
computer modeling of dynamics based on detailed
knowledge of structure, but does not accord particular
importance to higher-order properties of the system.
Kriete et al. (2010), (2011) take a similar approach,
though higher-order properties have a larger role.
From a different angle, an increasing number of
studies are working to map networks (Csermely and
S}oti 2006; Hoffman et al. 2014; Xue et al. 2007) and
thus establish structure without particular regard to the
other features listed. This is part of a more general
tendency to use high-throughput technologies to
generate and integrate large amounts of data on aging
(e.g. de Magalha˜es et al. 2009; de Magalha˜es and
Toussaint 2004), though such approaches may not
really fall within Kitano’s framework for systems
biology, absent a link to dynamics, control etc. For
example, weighted correlated gene network analysis
can take large volumes of biological data and organize
it into sub-networks based on the correlations among
the molecules. Each sub-network can then be summa-
rized to generate a signal of activity (Langfelder and
Horvath 2008; Zhang and Horvath 2005). Such an
analysis is very powerful, and can be used for multiple
purposes, including an understanding of dynamics as
well as for other objectives that may fall outside
systems biology. Obviously, the importance of these
studies is not determined by whether they can be called
‘‘systems biology.’’ There is a role for all these
approaches, including bioinformatics, network ana-
lyses, structural maps, computer simulations of net-
work dynamics, and our statistical integration to
understand functional dynamics. Nonetheless, impre-
cision with terms such as complexity, systems, and
network, combined with methodological overlap, can
sometimes obscure the fact that these approaches pose
distinct and complementary biological questions.
One of the largest challenges with network ap-
proaches to aging is the precision needed in order to
successfully understand network dynamics (Pearson
et al. 2013). In theory, we might build a map of how
every molecule relates to every other molecule and then
use differential equations to model system behaviour.
In practice, we are likely decades away from even
identifying all the molecules, much less understanding
their dynamic relationships, and it is hard to imagine we
will ever have computers powerful enough to run such
models. Precisely because the networks are complex
dynamic systems, the consequences of missing or
slightly erroneous information in network construction
are difficult to infer and could be large (Gutenkunst
et al. 2007). For example, Fig. 1 shows the very
different outcomes in a simple 3-molecule control
network based on linear versus logistic functions
describing relationships. Fuzzy logic and appropriate
sensitivity analyses may partially circumvent such
concerns, at least at the cellular level (Kriete et al.
2010). Nonetheless, efforts to understand network
function may also require top-down approaches (Pear-
son et al. 2013), such as those used in our research.
One of the most exciting new directions in
complexity in aging research comes from the literature
on how robustness is achieved in complex systems
(Carlson and Doyle 2000). Robustness is a ‘‘property
that allows a system to maintain its functions against
internal and external perturbations’’ (Kitano 2007).
Following on this literature, Kriete (2013) suggests
that in highly optimized systems overall robustness is
zero-sum, such that a gain in a certain type of
robustness causes a fragility elsewhere. He uses this
principle to suggest that evolution of robustness
implies the evolution of trade-offs, and thus that aging
may be a side effect of other aspects of evolutionary
optimization given the specific system-level con-
straints in complex systems such as organisms. Such
an understanding of robustness also integrates well
with our understanding of hormetic responses to stress
during aging (Rattan 2008).
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Lastly, loss of complexity during aging is a specific
hypothesis that reflects an understanding of an organ-
ism as a complex system (Lipsitz 2004; Lipsitz and
Goldberger 1992). Loss of complexity posits that an
organism is a sufficiently sophisticated entity that,
when in good health and functioning well, it will
exhibit fractal patterns and chaotic or complex
patterns of structrure and change. Some of this
complexity diminishes during the aging process,
presumably indicating that the organism is losing the
capacity to control the multi-dimensional, conditional,
and dynamic processes underlying the complexity.
Loss of complexity is not necessarily based on a
network of molecular interactions. In fact, the primary
examples of loss of complexity are traits such as heart
rate variability and branching structure of vessels
(Lipsitz and Goldberger 1992), traits that are not well
explained through a network understanding of organ-
isms. Loss of complexity may at least partly explain or
characterize aging, and it may influence or be influ-
enced by aspects of complex system dynamics.
Complex systems dynamics and physiological
organization
Most research on physiological regulation today
proceeds molecule by molecule. The basis of this
reductionist approach is the idea that if we can
understand the role of each molecule in regulating
other molecules and being regulated by them, we will
be able to understand how physiological systems or
entire organisms function. This approach is not
without merit—many successful pharmaceutical prod-
ucts have been developed by understanding molecular
interactions and developing compounds to intervene
in these interactions. However, most potential phar-
maceutical products never pan out, and many that do
are found to have unexpected side-effects, short or
long-term (Ahn et al. 2006; Ju¨ni et al. 2004). Though it
would be a mistake to put too much emphasis on the
reductionist-holist distinction (Kirkwood 2011), this
reflects certain limits of a purely reductionist
approach.
To understand why this is, we need a coherent
model of how physiological systems are structured and
how they evolve. A starting point is the raison d’eˆtre
of these systems: they exist to help organisms maintain
homeostasis, and to adjust this homeostasis as neces-
sary in response to changing environmental conditions
or internal physiological conditions (Cohen et al.
2012; Kitano 2007; Kriete 2013). The term ‘‘home-
ostasis’’ is imperfect in this context, given that
organisms are dynamic entities in constant flux. Here,
I do use the term homeostasis, but with a broad
conception that what is static is not the state of the
molecules, but that the organism is maintained in or
adjusted to whatever physiological state may best
Fig. 1 Linear and logistic relationships among molecules can
produce vastly different functional dynamics in the system.
Results are based on a simple simulation of three molecules, A,
B, and C, in which A up-regulates B, B up-regulates C, and C
down-regulates A. Over 1000 time steps, linear dynamics
produce a highly unstable, fluctuating system, whereas logistic
dynamics produce a more stable system. Accordingly, it is not
necessarily possible to predict the dynamics of a complex
system based solely on a map of what regulates what, without a
detailed understanding of the functional forms of the regulatory
dynamics
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serve its interests at the moment. This is consistent
with its original definition (Cannon 1932), despite
later criticism. Organisms achieve homeostasis
through robustness to perturbations (Kitano 2007).
For example, our diet changes slightly from day to
day; it would not do for small changes in intake of
vitamins, phytoestrogens, etc. to cause major shifts in
physiological state. At the same time, physiological
state does need to change in coherent ways—for
example, to enter a breeding state, to digest a meal, to
mount a stress response, or with circadian rhythms.
Organisms thus need physiological systems that are
largely robust to minor perturbations, and that can
make coherent shifts in physiological state as neces-
sary. Moreover, if a problem arises in the regulation,
there is no external force that can intervene to restore
homeostasis. Accordingly, both robustness and de-
sired shifts in physiological state must result directly
from the organization of molecules in a regulatory
network.
At the level of the organism, I call these ‘‘physio-
logical regulatory networks’’ (PRNs, Fig. 2) (Cohen
et al. 2012). Within an organism, all biologically
active molecules can be considered part of a single
large PRN. Figure 2 is a simple caricature – there are
hundreds if not thousands of sub-networks, and many
molecules have yet to be discovered. The key point of
the figure is the structure of regulation: it is not simply
hierarchical (from the top down), but also bottom-up
and with substantial direct cross-talk among systems.
For example, vitamin E has important roles in both
maintaining oxidative balance and in the immune
system (Chew 1995). The bottom-up effects and cross-
talk create feedback loops, a key structural feature of
networks that helps them maintain homeostasis (e.g.
through negative feedback) or shift physiological
states (e.g. through positive feedback) (Cinquin and
Demongeot 2002; Wiener 1961). Another key struc-
tural feature of PRNs is redundancy (Kitano 2002).
Redundancy helps ensure that problems in one small
part of the PRN can be contained, and thus that the
PRN is not overly sensitive to minor perturbations.
These structural features mean that PRNs can be
formally considered complex dynamic systems
(Holland 1992; Kier and Witten 2005), much like
weather systems and ecological networks (e.g.
Dunne et al. 2002). However, PRNs have one key
difference from many other complex systems: they
have been shaped by natural selection for a specific
purpose, i.e. to maximize organismal fitness (Cohen
et al. 2012). Even undirected networks such as
weather systems and ecological networks can
demonstrate coherent structure; this is a result of
self-organizing properties that can emerge in com-
plex systems (Kauffman 1993). But in PRNs and
other biochemical networks this organization should
be particularly clear and should relate directly to
traits that influence fitness.
Indeed, what we know about PRN structure
strongly supports this model. While some molecules
may play key roles coordinating function across
systems (integrators, Fig. 2) (Martin et al. 2011),
PRN function is relatively robust to perturbations in
levels of these integrators. For example, polybromi-
nated diphenyl ethers (PBDEs) are endocrine disrup-
tors that have been shown in animal models to be able
to disrupt growth processes by mimicking thyroid
hormones (Suvorov et al. 2008; Zhou et al. 2001).
Nonetheless, in human epidemiological data there is
no evidence for an effect of PBDEs on growth rates.
Increased PBDE levels result in decreased thyroid
levels (Abdelouahab et al. 2013), but no change in
birth weight (Y. Serme and A.A. Cohen, unpubished
data). This suggests that thyroid hormone production
decreases as a response to PBDEs, and that up to a
certain point PBDEs simply replace thyroid hormone.
Only when levels are particularly high or other factors
contribute does major physiological disruption occur.
This is a good example of how control of PRNs is
diffuse: only rarely does a single molecule exert
exhaustive control over a process, and often redun-
dancy and feedback combine to assure a functional
stability. Additional support for this is seen in the
failure of many gene knockouts to produce major
changes in phenotype (Barbaric et al. 2007).
The model of physiological organization outlined
here is not revolutionary—in fact, most of its elements
can be found in introductory biology courses, to say
nothing of systems biology textbooks and reviews
(Kitano 2002; Klipp et al. 2005). Nonetheless, its
consequences are important. It suggests that the best
way to understand physiological system state is
neither by using single molecules to describe system
state, nor by creating an exhaustive map of all
molecules and their relationships. Rather, key aspects
of system state might be measured with small numbers
of molecules, and the precise choice of molecules
might not be that important, because system state is a
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diffuse property of the network as a whole. Any single
molecule might measure this state with a large amount
of error, but as the number of molecules increases so
does the signal, with diminishing returns for each
additional molecule. This is encouraging: it implies
that with relatively simple multivariate statistics
applied to small numbers of markers (\50) we may
be able to decode how PRNs are structured and to
measure the state of an individual. This model also
suggests that complex systems dynamics may be key
to understanding aging, i.e., that aging may be to some
degree an emergent property of PRN function. We
wanted to understand to what extent these kinds of




The general framework just described suggests that
physiology may be organized in part around what I call
EPPs. An EPP is a process controlling a key aspect of
regulation through dynamic interactions among large
numbers of molecules in a way that cannot be easily
understood by mapping the direct regulatory relation-
ships among the molecules. Emergence in physio-
logical systems is generally discussed in terms of
emergent properties: robustness, modularity, etc.
However, there is good theoretical reason to suspect
that emergence can occur for processes as well as for
Fig. 2 A simplified, partial schematic of a physiological
regulatory network (PRN). Red arrows indicate top-down
control, such as steroid hormone modulation of immune
function. Purple arrows indicate feedback effects, such as
antioxidant effects on glucocorticoids. Light-blue arrows
indicate direct interactions among subnetworks, such as immune
regulation by dietary antioxidants. Green arrows indicate direct
effects of the environment on subnetworks, such as content of
antioxidants in the diet. Yellow arrows indicate environmental
regulation of integrators, usually via the central nervous system
(CNS). System-level properties of the PRN exist at different
levels, including state within individuals (e.g. dysregulation)
and species-level structure (modularity). Likewise, phenotype
can include individual- or species-level traits (e.g. health and
evolvability, respectively). Modularity is determined by the
proportion of potential light-blue arrows present; interconnect-
edness by the total number of arrows relative to molecules; and
robustness by the density of purple arrows resulting in negative
feedback effects. The particular structure of connections, as well
as their strengths and interactions, will determine how the PRN
responds at an individual level and evolves at the species level in
response to a changing environment. Adapted from Cohen et al.
(2012)
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properties. Unlike emergent properties, which can
often be measured in a standardized way across
different types of networks, emergent processes are
specific to the functional objectives of a given
network. For example, both ecological networks and
physiological networks might be highly modular (a
property), but it makes no sense to discuss regulation
of systemic inflammation (a process) in an ecological
network.
The concept of EPPs has not, to my knowledge,
been previously described in a way specific to
physiological regulation, though in complex systems
theory more generally the existence of such processes
was predicted over 20 years ago by Kauffman (1993).
Kauffman used simulations to show that complex
dynamic systems can have clear attractor states related
to attractor basins: within a multivariate state space,
there exist a number of distinct regions within which
regulatory networks cause a dynamic process that
leads the system state to converge on a single point,
such that even though the number of starting points
may be enormous, there are a limited number of
convergence points to which the system tends. This is
the equivalent of the tendency of water to flow to the
lowest point in a drainage basin: the number of local
valley bottoms is limited, even on a large landscape.
(The analogy breaks down due the presence of water
bodies such as rivers and lakes that stop the descent.)
The idea of attractor states fits well with the general
model of physiological regulation above because these
states are likely to correspond to key situations
organisms encounter, such as shifts between breeding
and non-breeding states.
Of course not all states that organisms need to
arrive at are discrete, and it is not hard to develop a
conceptual generalization of the attractor state model
to incorporate continuous variation in an organism’s
physiological state. Aging is a good example of this.
Many aging-related changes in physiology are likely
adaptations to other aging-related changes, adapta-
tions that minimize the impact of aging on the
organism. Such adaptation likely needs to be con-
tinuous rather than discrete, and the analogy would
thus be to attractor ‘‘trenches,’’ where there is not a
single point to which physiology converges, but rather
a series of points along a continuous axis. The system
will be able to converge to different points along this
axis in response to some additional control factor.
Note that this axis or trench could align with many
physiological parameters to reflect the continuous
adjustment of many different aspects of physiology in
a coordinated fashion.
As mentioned above, if control of which state an
organism is in depends too heavily on any single
parameter, the organism is at substantial risk of a
regulatory error should that parameter become abnor-
mal for any reason. Accordingly, we should expect
that control of shifts among attractor basins occurs in a
more sophisticated way involving feedback loops and
redundancy across many parameters. This would
reflect selection for PRN structures that increase
robustness to common problems while decreasing
robustness to rare problems (Kriete 2013).
Putting all this together, we should expect that
shifts among attractor states and/or along attractor
trenches would often be regulated by complex feed-
back mechanisms occurring among many molecules,
and that mapping the regulatory pathways of the
molecules would not necessarily give us clear insight
into what the attractor states/trenches are nor into how
those shifts result from the regulatory pathways.
Obviously, we neither expect nor observe that such
complex mechanisms are the only mechanisms of
physiological control. For example, insulin signaling
controls glucose metabolism in a rather straightfor-
ward way, and complex systems theory is not neces-
sary to explain the functional significance of this
pathway. Nonetheless, almost all research into physio-
logical regulation to date has been conducted as if all
key processes can be detected in the same way as
insulin signaling, and there is good reason to believe
that EPPs might exist and might control numerous
important processes for maintaining and adjusting
homeostasis.
Evidence
Some of our recent findings provide the first clear
empirical support for the existence of EPPs. In full
disclosure, we did not predict the existence of EPPs
and then confirm this empirically, but rather obtained
unexpected results and developed the concept of EPPs
as the most coherent explanation for these findings.
The principal result was the detection of unexpected
yet highly stable associations among a number of
biomarkers (Cohen et al. 2015b). We had used the
statistical method principal components analysis (see
‘‘Principal Components Analysis (PCA)’’) to try to
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understand links among 43 common clinical biomark-
ers during aging from the Women’s Health and Aging
Study (WHAS), expecting to be able to simplify our
dataset into summary measures of known systems.
Instead, the most important axis (i.e., PCA 1) cut
across traditional classifications of biomarkers, asso-
ciating particularly strongly with those relating to
anemia, protein transport, inflammation, and calcium.
Thinking we had perhaps made an error or that our
result was due to random processes in the data, we
replicated it in two additional datasets, InCHIANTI
and the Baltimore Longitudinal Study on Aging
(BLSA), as well as in multiple demographic subsets
of each dataset (male/female, black/white, younger/
older, etc.). In each case we were able to faithfully
replicate the axis, with versions calculated from
different datasets and subsets generally producing
scores correlated at r[ 0.9, often[0.95.
Principal Components Analysis (PCA)
Principal components analysis (PCA) is a data reduc-
tion method that can be used to condense a large
number of redundant variables into a smaller number
of independent variables. While PCA is a standard
method, it has a rarely appreciated potential to identify
underlying processes structuring the data (e.g. Cohen
et al. 2010). For example, if we applied PCA to a data
set of thousands of individuals for whom we measured
100 morphologic traits (height, weight, arm length, leg
length, waist circumference, nose width, etc.), we
would expect to be able to greatly simplify the dataset.
Arm length, leg length, and height are tightly corre-
lated and thus largely redundant. We thus might
expect the first composite variable (‘‘axis’’) generated
by the analysis to be an overall measure of size,
positively associated with all our measures. The
second axis might be a measure of skinniness/obesity,
with measures like height, arm length and leg length
juxtaposed against measures like waist circumference,
arm circumference, weight, etc. We would likely have
several other important axes as well. These axes would
provide a useful summary of the data: 5–10 variables
is easier to manage than 100. But critically they would
also provide insight into the biological processes
determining morphology. If a certain gene controls
aspects of development that cause nose width and
finger circumference to covary, this would show up in
our axes. If fat composition in the diet systematically
affects where fat is deposited, this will also show up in
our axes. Careful interpretation of PCA axes can thus
yield important substantive insight into underlying
processes structuring the data.
It was clear that the physiological axis we had
detected in WHAS, InCHIANTI, and BLSA represent-
ed some underlying process structuring the correlations
among the biomarkers in a consistent way across
populations and sub-populations, but it was not yet clear
if this process was biologically interesting. We repli-
cated the analyses after controlling each biomarker for
age and obtained the same signal again, confirming that
we were not measuring some proxy for age. We tested
for an association with hepcidin, a recently discovered
hormone thought to be important in regulation of some
of the systems associated with our process (Nemeth
et al. 2004), but the correlation was weaker than for most
of the individual biomarkers used. We tested for the
stability of the axis across datasets compared to the
stability of the individual biomarkers, both in terms of
correlations with age and correlations with each other,
and showed that the axis is more stable than any of the
individual biomarkers. At this point, we concluded that
the most likely explanation for the process we detected
is that it represents an axis of physiological regulation
integrating multiple systems, and that appears to
function outside the direct regulatory control of any
single molecule or pathway. We noted that it appears to
increase exponentially with age, and that it predicts
mortality and clinical frailty (but not chronic diseases)
after controlling for age. In other words, it appears to be
an EPP that is implicated in aging but not chronic
diseases.
While the process we detected, which we call
‘‘integrated albunemia’’ (PCA1, no relation to albu-
minenia), appears to be a clear example of an EPP, it is
not the only likely example. The second axis from the
same analysis appears to represent metabolic syn-
drome based on strong associations with lipids,
glucose, and inflammation (Cohen et al. 2015b).
Metabolic syndrome (Grundy et al. 2004) fits the
definition of an EPP presented above. Likewise,
inflamm-aging (a suite of changes in inflammatory
regulation with age, Franceschi et al. 2000) appears to
represent another EPP. In another recent study, we
showed that inflamm-aging is characterized not sim-
ply by up-regulation of pro-inflammatory markers, but
by simultaneous up-regulation of both pro- and anti-
inflammatory markers, suggesting that it represents a
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coherent shift in system state rather than a clear
outcome of a simple regulatory pathway (Morrisette-
Thomas et al. 2014).
All three of these examples of potential EPPs are
still tentative, in that we cannot definitively exclude
the possibility of simple molecular control mechan-
isms, nor of other potential explanations. Nonetheless,
for the reasons listed above, there is good reason to
suspect that EPPs might exist, and these examples
appear to exhibit the predicted properties. Interesting-
ly, all three represent either pathological changes in
system state or adaptations to pathological changes (it
is not easy to distinguish which). Nonetheless, there is
no reason to suspect that EPPs would be limited to
progression of aging-related pathologies; indeed, we
would predict that if EPPs are a common feature of
physiological organization, they should also exist to
help organisms transition along ‘‘attractor trenches’’
even when no point along the trench represents a more
pathological state than any other.
Physiological dysregulation
Overview
The second major branch of our research has focused
on quantifying physiological dysregulation. In some
sense, physiological dysregulation during aging is
trivial: clearly, many aspects of physiology and
regulation function less well during the aging process.
However, we use the term in a more restricted and less
trivial sense, referring specifically to a gradual and
generally irreversible loss of regulatory control
originating from structural instabilities in regulatory
networks. All complex systems have some tolerance
limits to changing conditions. For example, there exist
temperatures, blood glucose levels, etc. that are simply
and immediately fatal for an organism. As mentioned
above, highly optimized complex systems have gen-
erally evolved to tolerate as wide a range of common
conditions as possible, while remaining frail/suscep-
tible when faced with more abnormal conditions
(Kriete 2013). The question is, what happens when a
system/organism is pulled slightly outside its optimal
tolerance range? Does it either die immediately, or
survive as if nothing happened? Or does it survive, but
with its overall system state slightly modified and
unable to fully return to complete homeostasis? If this
latter possibility exists (and it is by no means clear it
does), that would be what I call physiological
dysregulation. Note that this model does not neces-
sarily imply that aging/dysregulation could be avoided
simply by maintaining perfect conditions, because
organisms may not have perfect tolerance for the
varying internal conditions that they will inevitably
undergo during their life course.
Unlike with EPPs, we hypothesized a priori that
physiological dysregulation is a major driver of the
aging process, perhaps even largely sufficient in some
cases to explain most of aging as we know it. We thus
set out to find ways to detect a signal of physiological
dysregulation. We started with the Anna Karenina
principle: ‘‘All happy families are happy in the same
way, but each unhappy family is unhappy in its own
way.’’ Taking the analogy to physiology, all well-
regulated systems are relatively similar, but there are a
multitude of ways in which things can go wrong. This
analogy was first proposed to me by Arun Karla-
mangla. Using this principle, we hypothesized that
individuals with a normal biomarker profile should
generally be healthier and younger than those with an
abnormal profile.
Evidence
In order to measure how normal a profile is, we applied
a measure of statistical distance. Statistical distance is
a way to quantify how different a vector of values (e.g.
a biomarker profile) is from some standard profile.
Specifically, we used the Mahalanobis distance (DM)
as a measure of how normal or abnormal an indi-
vidual’s overall biomarker profile is (Cohen et al.
2013; Mahalanobis 1936). Because biomarkers are
correlated, it is not possible to evaluate how unusual a
profile is based solely on how unusual each biomarker
is. For example, it is about equally rare for adults in the
US to be 194 cm tall or 140 cm tall, but the
combination of 140 cm with 133 kg is much rarer
than the combination of 194 cm with 133 kg (Fig. 3a).
Similar principles apply to biomarkers (Fig. 3b).
Standard clinical and research approaches to biomark-
ers consider them one at a time, but DM provides a
simple way to adjust for their joint probability
distribution. We hypothesized that, under the PRN
model above, having an abnormal or unusual biomark-
er profile as measured by DM would be a sign of
physiological dysregulation (i.e., deviation from
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homeostasis), and that physiological dysregulation in
turn was important in aging. We made a number of
specific predictions to test this hypothesis:
1) DM should increase with age.
2) High DM should be associated with higher
mortality and adverse health outcomes, control-
ling for age.
3) The signal of DM should increase as more
markers are used to calculate it, but with
diminishing returns for each additional marker.
4) The precise choice of markers should not matter
too much, as long as they are broadly represen-
tative of the system or organism in question.
5) The signal of DM should increase if the ‘‘nor-
mal’’ profile is calculated based on a relatively
young, healthy sub-population.
6) These results should be broadly replicable and
stable across populations and species.
Indeed, we can now confirm all of these quite
convincingly using data on 44 common clinical
biomarkers from the same aging cohort studies
mentioned above in the PCA analyses (Cohen et al.
2013, 2014, 2015a; Milot et al. 2014a, b). DM
increases with age, probably exponentially, and the
curves are consistent across WHAS, BLSA, and
InCHIANTI (Fig. 4; Milot et al. 2014b). A very
different group of markers gives a very similar pattern
in a fourth cohort study, NuAge, based in Quebec
(unpublished data). DM predicts mortality and clinical
frailty after control for age. It is also associated with a
number of chronic disease measures—very consis-
tently with total number of comorbidities and heart
disease, somewhat less consistently with diabetes, and
only rarely for cancer (Cohen et al. 2014, 2015a; Milot
et al. 2014b).
Many of our analyses have been replicated across a
very large number of biomarker combinations. Our
initial analyses used a group of 14 markers identified
through a statistical selection procedure, and were
replicated on every combination of these 14, i.e.
16 383 combinations (Cohen et al. 2013), (2014). We
then used the full set of 44, testing 5000 random
combinations for each possible number between 1 and
44, or all combinations when less than 5000 existed
(Cohen et al. 2015a). We consistently found that
Fig. 3 A general, 2-dimensional example of Mahalanobis
distance (DM) based 30,000 ? adults in the NHANES dataset.
a gives the relationship between height and weight (an intuitive
example), and b between total cholesterol and vitamin E (two
biomarkers in our data sets). The correlations between these
variables are r = 0.45 and 0.54, respectively. The concentric
ellipses represent, from inside to outside, ellipses that should
contain 0, 10, 50, 80, 95, and 99 % of the observations, based on
the combination of the correlation, means, and standard
deviations. DM here reflects how rare any height-weight or
cholesterol-vitamin E combination is, and thus has an equal
value for all points on the same ellipse, as indicated in red.
Because DM incorporates the correlation into the calculation, it
reflects the fact that certain combinations may be more unusual
than expected based solely on how rare the values are separately.
For example in a, the point in the upper left (height = 140 cm,
weight = 133 kg) has a DM of 6.64, substantially higher than
DM = 5.24 for the point on the 99 % ellipse in the upper right
(height = 194 cm, weight = 133 kg) despite the fact that
heights of 140 and 194 cm are equally rare in the population
(99.6th percentile). Accordingly, DM correctly reflects the fact
that it is much rarer to be short and heavy than tall and heavy. In
practice, DM applies this principle to large numbers of variables
simultaneously, though visualization is hard beyond two
dimensions
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including more markers produced a stronger signal,
but with diminishing returns, as predicted. We showed
that two mutually exclusive groups of biomarkers still
tended to produce DMs that correlated relatively well
(r = 0.4–0.5 when n = 20 per group). There was
moderate heterogeneity in results across combina-
tions: for example some predicted one outcome more
strongly, others another. Nonetheless, the general
tendencies were consistent. Few enough combinations
were associated with cancer that this could be due
solely to sampling processes and false positives;
cardiovascular disease was almost always positively
associated with DM, though sometimes not significant-
ly depending on the combination.
In addition to validating these results in four human
datasets, we applied the same technique to a dataset on
11 biomarkers measured monthly in 32 captive red
knots (Calidris canutus), a shorebird (Milot et al.
2014a). DM was clearly predictive of the two health/
performance measures available, a foot inflammation
score (positive association) and maximum aerobic
capacity (negative association). The 11 biomarkers
had already been measured for other reasons, showing
that the principal can be applied to biomarkers chosen
more-or-less randomly.
Lastly, we have recently shown that DM can be
calculated not just globally, at the organism level, but
also meaningfully for distinct physiological systems
(Li et al. in press). DM calculated based on biomarkers
for lipid, electrolyte, oxygen transport, vitamin, liver
function, and white blood cell types showed the same
traits as global DM, but DM in each system was only
weakly correlated with DM in the others after control
for age. This suggests that dysregulation may proceed
largely independently within each system, but with the
potential for feedback effects such that a global level
can also be meaningfully measured. This result is
crucial for our ability to take inference about dys-
regulation to a finer biological scale than the whole
organism, and suggests a long-term direction for
understanding how lower-order processes produce
higher-order ones during aging.
It is surprising that our results so consistently and
strongly confirm the utility of DM as a measure of
dysregulation, given how crude the measure is. It
requires us to assume (a) that the ideal biomarker
profile is the average profile; (b) that this ideal profile
is identical for all individuals at all ages, sexes, and
physiological states, and (c) that the distribution of
profiles in biomarker space is multivariate normal. All
three of these assumptions are clearly false, and may
sometimes not even be approximately true. We are
working on better ways to estimate of the centroid
(i.e., optimal profile) and to relax the supposition of
multivariate normality (e.g. Ekstro¨m 2011; Liu et al.
1999). The fact that DM works well despite the
crudeness of these assumptions suggests that the true
signal (i.e., the signal we would detect with an optimal
method) is very strong and biologically important.
Taken together, these results show that DM does
measure physiological dysregulation as an emergent
property of system state, and that physiological
dysregulation is an important part of the aging process.
They do not, however, show whether dysregulation is
a primary cause of aging or a result of other, upstream
Fig. 4 Estimated trajectories of log-DM with age at the
population (solid black line) and individual (dotted lines) levels
for the InCHIANTI cohort based on quadratic Bayesian multi-
level models. These models estimate an overall (population)
quadratic function for change in DM with age, as well as
individual deviations from this function. Each individual’s
trajectory is estimated with substantial error, but overall
estimates of the heterogeneity of trajectories are robust with
the sample sizes available. Individual trajectories are shown for
ten individuals selected randomly in the dataset as an example.
Inference is based on statistical distance of 43 common clinical
biomarkers (albumin, glucose, cholesterol, etc.) measured in
1022 individuals aged 21–96, with up to four visits per
individual. While individual heterogeneity in level and rate of
change in DM is significant, the general trend toward increasing
and accelerating DM with age is also clear. More complete
analyses and details are available in Milot et al. (2014b)
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processes. The robustness to choice of biomarkers is
strong enough to confirm the general physiological
model proposed, but weak enough to imply that
greater detail of specific processes will be important to
incorporate going forward.
Discussion
Overall, our research to date provides convincing but
not yet ironclad evidence for a role of complex
systems dynamics in aging. Our findings on integrated
albunemia, metabolic syndrome, and inflamm-aging
are highly consistent with EPPs, and thus suggest a
model of physiology in which function is not neces-
sarily determined through distinct, clearly decipher-
able molecular pathways, but also through complex
interactions among large numbers of molecules, at
least in some cases. For all three potential EPPs
discussed here higher scores indicate worse health.
This may indicate that they are pathological processes,
or that they are adaptive responses to other changes in
system state with age, or a combination of the two.
However, there may also be other EPPs that are not
involved in aging at all, and that help organisms
control transitions among key physiological states.
Likewise, physiological dysregulation appears to
be a separate type of complex systems dynamic
involved in aging. When we began our study, it was
not clear whether more-or-less random combinations
of 10–15 common biomarkers could provide a coher-
ent signal of overall system state. Many of these
markers are not themselves correlated with age in any
consistent way (Cohen et al. 2015b). Our findings thus
provide clear support for a specific definition of
physiological dysregulation: as a gradual inability of
physiological systems to return to a baseline (e.g.
homeostatic) state due to complex interactions at the
system-level. Obviously, there is no single optimal
physiological state to which all organisms attempt to
return (Kitano 2007); the optimal state must shift with
conditions, and substantial work remains to outline
how dysregulation measures interact with an organ-
ism’s changing physiological needs. However, this
limitation makes it all the more surprising that we do
consistently find that a simple measure of how
aberrant a biomarker profile is consistently predicts
everything we would expect from a measure of
biological age (Klemera and Doubal 2006; Levine
2013). Despite this, I would take a cautious approach
relating DM to biological age. The semi-independent
dysregulation in different systems we find means that
there is no single, universal definition of biological
age. Biological aging is likely multi-dimensional, and
this is reflected in the imperfect correlations among
DM generated from different biomarker combinations.
It would appear that our analyses present the first
clear demonstration of generalized physiological dys-
regulation as a system-level property during aging.
This finding is unsurprising, given a number of
excellent previous studies. For example, Fried et al.
(2009) showed non-linear changes in biomarkers
across systems during aging. Govindaraju et al.
(2014) showed complex interactions among markers
of cardiac function during aging. Arbeev et al. (2011)
showed that individual biomarkers exhibit a loss of
homeostatic dynamics during aging. Yashin et al.
(2010) showed that dynamics of biomarkers during
aging may be at least as important as static levels. Dan
Belsky (pers. comm.) showed that changes in
biomarker profiles characteristic of aging start early,
at least by the 30 s in humans. Southworth et al. (2009)
showed that gene expression profiles in mice become
increasingly uncorrelated with age.
Physiological dysregulation as we detect it is
consistent with many of the more clinical conceptu-
alizations related to homeostasis (Ferrucci 2005; Fried
et al. 2005; Seplaki et al. 2005). In particular, some of
the mathematical properties of the robustness to
biomarker choice resemble those of the frailty index
(Howlett et al. 2014; Searle et al. 2008) and suggest
that DM may be detecting the frailty process well
before it reaches clinical manifestations. This idea is
somewhat at odds with the idea of integrated albune-
mia as the basis of frailty, and considerable work
remains to identify which if either of these processes is
more important in frailty’s etiology, or even whether
frailty represents a coherent biological process.
Our work has various links to the other approaches
to complexity in aging outlined above. Complex
systems dynamics such as we detect do not contradict
the possibility for more additive, multi-factorial pro-
cesses (Kirkwood 2005; Weinert and Timiras 2003).
The underlying model of physiology is quite similar to
the model of cellular regulation supposed by Kriete
(2013) in describing the role of robustness in aging. His
approach is complementary to our approach in that it
uses the principle of robustness to arrive at general
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insights into trade-offs and the evolution of aging; we
attempt to quantify functional outputs of complex
system dynamics at the individual level, with potential
implications at evolutionary scales. The relationship
between loss of complexity (Lipsitz 2004; Lipsitz and
Goldberger 1992) and our approach to network state
and dysregulation is hard to discern intuitively, and
empirical studies will likely be needed to establish any
links. Our results would appear to suggest that there
may be both gains and losses of complexity with aging:
the increases in DM we observe with age demonstrate
greater variation in physiological state with age. The
question then becomes, is variation in these traits
equivalent to complexity? There is substantial poten-
tial for research to bridge these approaches, such as
studies examining how short-term temporal variation
in DM changes with age.
Most of our research to date has been at the organismal
level, as has the research on physiological dysregulation
more broadly and on loss of complexity. In contrast,
much of the work on multi-factorial aging and on
robustness focuses on cellular aging. One of the major
challenges going forward is to understand how these
levels interact, and whether one has primacy over the
other in the aging process. One hypothesis would be that
cellular aging causes organism-level physiological dys-
regulation, but that variation in aging across species
depends on the species-level robustness of organism-
level PRNs to withstand this dysregulation. The statistical
approaches we have developed to measure complex
system dynamics could also be applied to cellular
networks, and it will be important to assess whether
cellular dysregulation is linked to cellular senescence in
the same way that organism-level dysregulation appears
related to organismal senescence.
Overall, it is becoming increasingly clear that
complexity generally, and complex network dynamics
specifically, play important roles in the aging process.
It remains to be seen exactly what these roles are, and
to what extent other processes are important as well. I
suspect but cannot yet prove that dysregulation is itself
a major driver of the aging process. If this is correct,
there are substantial impacts for understanding both
the mechanisms and evolution of aging. Aging rates
across species would be determined largely by their
ability to resist dysregulation. There are also impacts
for medical research on aging: if dysregulation of
complex networks is a crucial aspect of aging and is
universal in mammals, there is little hope that
rejuvenation therapies will be able to do much more
than serve as a speed bump during the aging process.
Conversely, understanding how lifestyle and genetic
background affect dysregulation rates may offer
substantial hope for improving health span.
I have little doubt that there are other fruitful
approaches to the complex systems dynamics of aging
waiting to be explored. Research to date has barely
scratched the surface, and a combination of recent
findings and basic principles of biological organiza-
tion suggest that these dynamics play an important role
in structuring the aging process, both on a mechanistic
and an evolutionary scale. If there is anything we have
learned after decades of research on aging mechan-
isms, it is that there is unlikely to be any silver-bullet
explanation, even if that explanation is relatively
broad, such as complex systems dynamics. Nonethe-
less, this field remains one of the most promising and
least explored aspects of aging.
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